Table 3.
Significant KEGG pathway terms.
| Species | KEGG terms | Benjamini |
|---|---|---|
| E. coli | Metabolic pathways | 3.30E-08 |
| Biosynthesis of amino acids | 1.00E-06 | |
| Biosynthesis of secondary metabolites | 2.40E-04 | |
| Biosynthesis of antibiotics | 7.40E-04 | |
| Lysine biosynthesis | 3.30E-03 | |
|
| ||
| H. sapiens | Biosynthesis of antibiotics | 3.70E-10 |
| Metabolic pathways | 2.80E-09 | |
| Ribosome | 3.40E-08 | |
| Valine, leucine, and isoleucine degradation | 1.30E-06 | |
| Carbon metabolism | 6.20E-06 | |
| Oxidative phosphorylation | 1.10E-05 | |
| Parkinson's disease | 2.60E-05 | |
| Citrate cycle (TCA cycle) | 1.00E-04 | |
| Huntington's disease | 4.10E-04 | |
| Alzheimer's disease | 7.80E-04 | |
| Aminoacyl-tRNA biosynthesis | 1.00E-03 | |
| Butanoate metabolism | 3.40E-03 | |
| Proteasome | 8.20E-03 | |
|
| ||
| M. musculus | Metabolic pathways | 6.20E-26 |
| Parkinson's disease | 8.50E-11 | |
| Oxidative phosphorylation | 3.40E-10 | |
| Nonalcoholic fatty liver disease (NAFLD) | 1.00E-09 | |
| Huntington's disease | 2.80E-09 | |
| Alzheimer's disease | 1.40E-08 | |
| Ribosome | 3.30E-07 | |
| Peroxisome | 1.80E-06 | |
| Glycine, serine, and threonine metabolism | 1.50E-05 | |
| Pyruvate metabolism | 9.00E-05 | |
| Propanoate metabolism | 2.40E-04 | |
| Valine, leucine, and isoleucine degradation | 1.90E-03 | |
| Glyoxylate and dicarboxylate metabolism | 3.10E-03 | |
| Biosynthesis of antibiotics | 5.60E-03 | |
|
| ||
| M. tuberculosis | Metabolic pathways | 1.00E-04 |
| Microbial metabolism in diverse environments | 2.50E-04 | |
| Biosynthesis of antibiotics | 4.40E-04 | |
| Biosynthesis of secondary metabolites | 1.00E-02 | |
| Propanoate metabolism | 1.00E-02 | |
|
| ||
| S. cerevisiae | Metabolic pathways | 5.20E-05 |
| Biosynthesis of amino acids | 3.30E-04 | |
| 2-Oxocarboxylic acid metabolism | 7.90E-04 | |
| Biosynthesis of antibiotics | 3.50E-03 | |
| Oxidative phosphorylation | 3.50E-03 | |